Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The renin pseudogene (ENSG00000226973) is a nonfunctional genomic locus that shows sequence homology to the functional human renin gene (REN) but contains one or more mutations that prevent it from producing active renin protein. Pseudogenes like this arise through gene duplication or retrotransposition events followed by disabling mutations, such as frameshifts or premature stop codons. While some pseudogenes can be transcribed and might influence gene expression through regulatory RNAs, most—including the renin pseudogene—lack known physiological or pathological roles and are not drug targets[1][2][3][4][5]. This entry should not be confused with the functional Renin protein, a clinically relevant target in hypertension and cardiovascular diseases. Key points: - The renin pseudogene is *not* a therapeutic target or druggable entity. - It is a nonfunctional DNA segment, not a protein-coding gene, enzyme, receptor, or transporter. - Any reference to therapeutic modulation or biomarker status for this locus is incorrect in biomedical and clinical contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Renin pseudogene.